28.01
price up icon5.54%   1.47
after-market 시간 외 거래: 28.10 0.09 +0.32%
loading

Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스

pulisher
Jul 23, 2025

Is Summit Therapeutics Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Meet the Biotech Stock That Rocketed 775% Higher - AOL.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Summit Therapeutics Inc. stock priceTremendous growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Summit Therapeutics Inc. stockExplosive capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Summit Therapeutics Inc. (SMMT) And Encourages Investors to Connect - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc.SMMT - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results - The Motley Fool

Jul 22, 2025
pulisher
Jul 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Summit Therapeutics Inc. (SMMT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Summit Therapeutics Inc. (SMMT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

Trading (SMMT) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 20, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Shares Acquired by Cerity Partners LLC - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

Summit Therapeutics Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 02:49:19 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Summit Therapeutics Inc. (SMMT) And Encourages Investors to Reach Out - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 18, 2025

Principal Financial Group Inc. Has $4.75 Million Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT) - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Summit Therapeutics: Not Entirely Positive HARMONi Data And Partnership Rumors (SMMT) - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Summit Therapeutics Inc. (SMMT) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 17, 2025

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy? - AOL.com

Jul 17, 2025
pulisher
Jul 17, 2025

10 Stocks Exploding Higher: Bitcoin Miners Dominate the List - Insider Monkey

Jul 17, 2025
pulisher
Jul 16, 2025

how summit therapeutics inc. stock performs during market volatilityAnalyst Grade Signals - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Summit Therapeutics Jumps 16% On Heavy Volume As Technicals Signal Bullish Breakout - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Summit Therapeutics Inc (SMMT) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jul 16, 2025
pulisher
Jul 16, 2025

Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Summit Therapeutics Inc. stock price move sharplyFree Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

H.C. Wainwright Keeps Their Buy Rating on Summit Therapeutics (SMMT) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

Why Summit Therapeutics Inc. stock attracts strong analyst attentionFree Trading Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors - MSN

Jul 15, 2025
pulisher
Jul 14, 2025

SMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 14, 2025
pulisher
Jul 14, 2025

BPAS - FinancialContent

Jul 14, 2025
pulisher
Jul 14, 2025

Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential - MSN

Jul 14, 2025
pulisher
Jul 10, 2025

Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Where are the Opportunities in (SMMT) - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 09, 2025

10 Stocks Going Wild - Insider Monkey

Jul 09, 2025
$103.44
price up icon 0.51%
$36.01
price down icon 0.25%
$22.87
price up icon 4.91%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):